Genetic Testing Support for Solid Tumor Cancer Patients
A Pilot Study of Genetic Testing Uptake Through Enhanced Oncology Nurse-Led Intervention
Recruiting
N/A
Interventional Study
Solid Tumor, Adult
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 60 (estimated)
- Sponsor
- University of California, Davis · Other
Who this trial is looking for
This trial is looking for adults with solid tumor cancers who may benefit from genetic testing. Participants will receive support from oncology nurses to help them understand the importance of genetic testing and how to start the process.
Are You a Good Fit for This Trial?
You may be able to join if
- I am an adult aged 18 or older.
- I have been diagnosed with a solid tumor cancer type.
- I am starting a new treatment or switching treatments.
- I am eligible for genetic counseling and testing based on guidelines.
- I have not had prior genetic testing or was tested before 2014.
You may not be able to join if
- I have had genetic testing with results available since 2014.
- I am scheduled for complex treatment education with an Advanced Practice Provider.
- I have cognitive impairments or severe psychological disorders.
- I have any condition that could affect my safety in this study.
- I am currently in another clinical trial that could affect the study results.
- I may not be able to follow all study procedures.
- I have a blood cancer.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Genetic factors are a significant determinant of the likelihood of developing various types of cancers. Identification of germline risk can have important implications for both patients and their families. Although estimates vary, pathogenic germline variants can be seen in \~3-17.5% of unselected patients with cancer with important clinical significance. Unfortunately, despite progress in multige…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults (≥ 18 years)
* Diagnosed with a solid tumor cancer type that has established guidelines suggesting the utility of genetic testing in treatment (breast, ovarian, prostate, pancreatic, colon, Lynch syndrome-related cancers (colorectal, endometrial, gastric, ovarian, pancr…
Contacts